Showing results (61-70 of 151) with videos related to
Sort By:
Pageof 16
Neurology|February 11, 2000
The association between APOE and dementia does not seem to be mediated by vascular factorsM Prince, S Lovestone, J Cervilla, et al.Biochemical Society Symposium|July 13, 2001
Apolipoprotein E gene and Alzheimer's disease: is tau the link?S Lovestone, B Anderton, J Betts, et al.Journal of Neurology, Neurosurgery, and Psychiatry|November 28, 2001
Psychosis and aggression in Alzheimer's disease: the effect of dopamine receptor gene variationC Holmes, H Smith, R Ganderton, et al.Acta Neuropathologica|December 14, 1999
Disturbance of Notch-1 and Wnt signalling proteins in neuroglial balloon cells and abnormal large neurons in focal cortical dysplasia in human cortexD Cotter, M Honavar, S Lovestone, et al.The Journal of Biological Chemistry|July 5, 2001
Functional differences of tau isoforms containing 3 or 4 C-terminal repeat regions and the influence of oxidative stressM A Utton, G M Gibb, I D Burdett, et al.The Journal of Biological Chemistry|November 15, 1991
Activation of casein kinase II by sphingosineO B McDonald, Y A Hannun, C H Reynolds, et al.Journal of Neurochemistry|August 1, 1996
In vitro phosphorylation of the cytoplasmic domain of the amyloid precursor protein by glycogen synthase kinase-3betaA E Aplin, G M Gibb, J S Jacobsen, et al.Journal of Molecular Graphics & Modelling|October 6, 2000
GB/SA water model for the Merck molecular force field (MMFF)A Cheng, S A Best, K M Merz, et al.Alzheimer Disease and Associated Disorders|January 1, 1995
Abnormally phosphorylated tau protein in senile dementia of Lewy body type and Alzheimer disease: evidence that the disorders are distinctC Strong, B H Anderton, R H Perry, et al.Journal of Neural Transmission (Vienna, Austria : 1996)|December 29, 2000
Muscarinic agonists reduce tau phosphorylation in non-neuronal cells via GSK-3beta inhibition and in neuronsO V Forlenza, J M Spink, R Dayanandan, et al.Pageof 16